Skip to content

INGENIO MRI/ FINELINE II Pacing System Data Collection in Patients Undergoing MRI

INGENIO MRI/ FINELINE II ImageReadyTM Pacing System Data Collection in Patients Undergoing Magnetic Resonance Imaging

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01890512
Acronym
INFINITE-MRI
Enrollment
20
Registered
2013-07-01
Start date
2013-06-30
Completion date
2014-01-31
Last updated
2016-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradycardia

Brief summary

The INFINITE MRI Study is a prospective, non-randomized, multicenter, single arm study aimed at collecting data on ImageReady™ MR Conditional Pacing System (consisting of an INGENIO™ MRI or ADVANTIO™ MRI pacemaker with FINELINE™ II Sterox or FINELINE™ II Sterox EZ endocardial pacing lead(s)) when used in the Magnetic Resonance Imaging environment under the labeled Conditions of Use.

Detailed description

Objective of the INFINITE MRI Study is to collect data on the ImageReady MR Conditional Pacing System in subjects undergoing a magnetic resonance scan (MRI). The ImageReady system has CE mark and enrolled patients will undergo MRI scan under the labeled Conditions of Use. Subjects considered eligible for this studty are already implanted with the system according to standard medical guidelines for PM implantation. The study is aimed at providing confirmatory data of no impact of MRI on device function, lead parameters and patient conditions. The study will collect standard device measurement through device interrogation pre- and post- MRI scan. MRI scan in this study is a non-clinically indicated procedure and is not planned for diagnostic purposes. Data from this study will be used to support the evidence of clinical performance of the ImageReady™ MR Conditional Pacing System following a MRI scan when used under the labeled Conditions of Use, and may be used to support regulatory submissions for the approval of the system where requested. The study has no primary endpoint and is not hypothesis driven.

Interventions

None listed

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or above, or above legal age and willing and capable of giving informed consent specific to national law; * Patients already implanted with the ImageReady™ MR Conditional Pacing System, single or dual chamber, including INGENIO™ MRI or ADVANTIO™ MRI pulse generators with FINELINE™ II Sterox or FINELINE II Sterox EZ endocardial lead(s), or accessories (see Table 5.1-1) according to standard medical guidelines for pacemaker implantation; * Willing and capable of participation to the procedures indicated in the protocol.

Exclusion criteria

* Patients implanted with pulse generator location outside of left or right pectoral regions; * Patients implanted with other cardiac-related implanted devices or accessories other than the ImageReadyTM MR Conditional Pacing System; * Abandoned leads or PGs; * Evidence of a fractured lead or compromised PG-lead system integrity; * Low life expectancy (\< 1 year); * Severe comorbidities that, according to clinical judgment, pose patient at risk to undergo MRI; * Pregnant women or women of childbearing potential

Design outcomes

Primary

MeasureTime frameDescription
Number of MRI Related Patient Adverse Events and/or Adverse Device Effects During MRI Visitone monthThe study is aimed at providing confirmatory data of no impact of MRI on device function and patient conditions. Confirmation of no MRI related patient adverse events and/or adverse device effects during MRI visit are assessed as follows: 1. no episodes of asystole, 2. no occurrence of sustained ventricular arrhythmias in the bore, 3. no loss of capture due to rise in pacing threshold.

Countries

Netherlands

Participant flow

Recruitment details

INFINITE MRI study started subject enrollment on 17 June 2013.Las subject was enrolled on 2 October 2013 and last subject follow up concluded on 17 January 2014. Study database was closed on 28 February 2014.

Participants by arm

ArmCount
ImageReady Pacemaker
patients previously implanted with a Boston Scientific MR Conditional pacemaker(ImageReady)
20
Total20

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyPhysician Decision1
Overall StudyProtocol Violation1
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicImageReady Pacemaker
Age, Continuous71.5 years
STANDARD_DEVIATION 11.5
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
1 / 20
serious
Total, serious adverse events
3 / 20

Outcome results

Primary

Number of MRI Related Patient Adverse Events and/or Adverse Device Effects During MRI Visit

The study is aimed at providing confirmatory data of no impact of MRI on device function and patient conditions. Confirmation of no MRI related patient adverse events and/or adverse device effects during MRI visit are assessed as follows: 1. no episodes of asystole, 2. no occurrence of sustained ventricular arrhythmias in the bore, 3. no loss of capture due to rise in pacing threshold.

Time frame: one month

ArmMeasureValue (NUMBER)
ImageReady PacemakerNumber of MRI Related Patient Adverse Events and/or Adverse Device Effects During MRI Visit0 number of MRI related patient adverse ev

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026